The burden of pediatric diarrhea: a cross-sectional study of incurred costs and perceptions of cost among Bolivian families by Rachel M Burke et al.
Burke et al. BMC Public Health 2013, 13:708
http://www.biomedcentral.com/1471-2458/13/708RESEARCH ARTICLE Open AccessThe burden of pediatric diarrhea: a cross-sectional
study of incurred costs and perceptions of cost
among Bolivian families
Rachel M Burke1†, Paulina A Rebolledo1,2*†, Sally R Embrey1, Laura Danielle Wagner1, Carter L Cowden1,
Fiona M Kelly1, Emily R Smith1, Volga Iñiguez3 and Juan S Leon1*Abstract
Background: Worldwide, acute gastroenteritis represents an enormous public health threat to children under five
years of age, causing one billion episodes and 1.9 to 3.2 million deaths per year. In Bolivia, which has one of the
lower GDPs in South America, an estimated 15% of under-five deaths are caused by diarrhea. Bolivian caregiver
expenses related to diarrhea are believed to be minimal, as citizens benefit from universal health insurance for
children under five. The goals of this report were to describe total incurred costs and cost burden associated with
caregivers seeking treatment for pediatric gastroenteritis, and to quantify relationships among costs, cost burden,
treatment setting, and perceptions of costs.
Methods: From 2007 to 2009, researchers interviewed caregivers (n=1,107) of pediatric patients (<5 years of age)
seeking treatment for diarrhea in sentinel hospitals participating in Bolivia’s diarrheal surveillance program across
three main geographic regions. Data collected included demographics, clinical symptoms, direct costs (e.g.
medication, consult fees) and indirect costs (e.g. lost wages).
Results: Patient populations were similar across cities in terms of gender, duration of illness, and age, but familial
income varied significantly (p<0.05) when stratified on appointment type. Direct, indirect, and total costs to families
were significantly higher for inpatients as compared to outpatients of urban (p<0.001) and rural (p<0.05) residence.
Consult fees and indirect costs made up a large proportion of total costs. Forty-five percent of patients’ families
paid ≥1% of their annual household income for this single diarrheal episode. The perception that cost was
affecting family finances was more frequent among those with higher actual cost burden.
Conclusions: This study demonstrated that indirect costs due to acute pediatric diarrhea were a large component
of total incurred familial costs. Additionally, familial costs associated with a single diarrheal episode affected the
actual and perceived financial situation of a large number of caregivers. These data serve as a baseline for societal
diarrheal costs before and immediately following the implementation of the rotavirus vaccine and highlight the
serious economic importance of a diarrheal episode to Bolivian caregivers.
Keywords: Societal costs, Economic burden, Diarrhea, Pediatrics, Health economics* Correspondence: preboll@emory.edu; juan.leon@emory.edu
†Equal contributors
1Hubert Department of Global Health, Emory University, Rollins School of
Public Health, Mailstop 1518-002-7BB, 1518 Clifton Road NE, Claudia N Rollins
Bldg. 6050, Atlanta, GA 30322, USA
2Division of Infectious Diseases, Emory University School of Medicine, Atlanta,
GA, USA
Full list of author information is available at the end of the article
© 2013 Burke et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Burke et al. BMC Public Health 2013, 13:708 Page 2 of 10
http://www.biomedcentral.com/1471-2458/13/708Background
In the developing world, acute gastroenteritis presents
an enormous public health threat to children under five
years of age, with an incidence of one billion episodes
and 1.9 to 3.2 million deaths per year [1]. Pediatric diar-
rhea incidence has been shown to be inversely related to
socioeconomic status, with children in poverty much
more vulnerable to acute diarrheal episodes [2].
Bolivia (per capita GDP of $4,700 [3]) is one of the
lowest-ranking countries in the Americas region in
terms of the Human Development Index (taking into
account measures of health, education, and income)
according to the United Nations Human Development
Report [4] and suffers from high rates of diarrhea-
related infant mortality. Out of every 1,000 live births,
54 children die before the age of five, with an estimated
15% of these deaths attributable to diarrheal illness [5].
The costs of these diarrheal episodes can have severe
financial consequences in a setting where 15.6% of
the population lives on less than $1.25 per day (2008
estimate) [5].
Acute gastroenteritis presents an economic burden to
both healthcare systems and patient families [6-8]. Al-
though there is a universal insurance program that bene-
fits Bolivian children under the age of five, not all
medications or diagnostic tests are covered. Further, if
medications are out of stock at the hospital, the family
may have to pay out-of-pocket at a non-hospital phar-
macy. Thus, Bolivian patient families may still face sub-
stantial out-of-pocket expenses and productivity losses
associated with pediatric gastroenteritis-related hospital-
izations and outpatient visits. Direct (“out-of-pocket”)
expenditures include all costs paid directly by the family,
encompassing medical costs (such as medications, tests,
or consult fees) as well as non-medical costs (such as
transportation or extra diapers) [9]. Indirect costs are
defined as the value of the time lost by a caregiver and
their spouse from income-generating activities during
the acute episode of diarrhea [10].
Incurred familial costs due to pediatric diarrheal epi-
sodes have been quantified in several different studies. In
Kenya (GDP per capita US$1,800 [11]) and Kyrgyzstan
(GDP per capita US$2,400 [11]), two countries with a rela-
tively similar economic situation to Bolivia, the estimated
average per-episode total familial costs (direct and indi-
rect) ranged from US$19.86 (Kenya [12]) to US$47.90
(Kyrgyzstan [13]) for hospitalized children. In Vietnam
(GDP per capita US$3,400 [14]) direct costs alone were
found to amount to US$31.83 per case in one study [6].
Findings in somewhat wealthier countries included total
incurred costs of US$215.88 [15] for hospitalized children
in Mexico (GDP per capita US$14,800 [16]) and direct
costs of US$12.89 [17] per case in Brazil (GDP per capita
US$11,900 [18]).In a low-resource setting like Bolivia, incurred costs
may sometimes represent a large proportion of a family’s
overall economy. This ratio, the total incurred costs for
a single diarrheal episode to the annual family income,
can be termed the “cost burden” [19]. While absolute
costs associated with pediatric diarrhea have been quan-
tified in various settings, few studies specifically examine
the relative measure of cost burden as it relates to
pediatric gastroenteritis. A review of the literature iden-
tified only two studies in low- and medium-income
countries (LMIC) that addressed cost burden using a
similar methodology as the present study. In a study set
in India (GDP per capita US$3,700), Mendelssohn et al.
found that direct costs incurred per diarrheal episode
ranged from 2.2% to 5.8% of the household’s annual in-
come [20]. In the aforementioned study in Kyrgyzstan,
Flem et al. found that family-incurred costs (including
direct and indirect) totaled 2.5% of the mean annual
household income [13]. Several studies have shown that
incurred familial costs can be difficult for families to pay,
causing some (particularly the already-impoverished) to
resort to borrowing money to cover these expenses
[20,21]. In the aforementioned study in India, more than
80% of lower-income households reported borrowing
money to cover direct costs, as compared to only 35.7% of
higher-income households [20].
Factors that may affect familial direct and indirect
costs include treatment setting (e.g. rural primary care
facilities versus urban referral hospitals) and appoint-
ment type (outpatient versus inpatient), though limited
studies have specifically sought to quantify the potential
effects of these characteristics. In the above-discussed
study by Mendelssohn et al., direct familial costs for hos-
pitalized patients in India were found to be significantly
higher at an urban referral hospital as compared to a
rural community hospital (p<0.001); direct costs were
also higher for outpatients, but not significantly so
(p=0.06) [20]. However, the proportion of direct familial
cost to annual family income for one episode of diarrhea
was high in both urban (5.8%) and rural (2.2%) hospitals
[20]. Two other studies conducted in China, one in rural
areas and one in urban hospitals, also showed higher
mean direct familial costs for diarrhea inpatients com-
pared to diarrhea outpatients (statistical significance not
reported) [20,22,23]. In three cities studied in Brazil, di-
rect familial costs associated with diarrhea outpatient
visits represented the largest proportion of overall direct
familial costs associated with diarrheal episodes (inclu-
ding hospitalizations), likely reflecting the greater num-
ber of outpatient visits compared to hospitalizations [17].
Pediatric diarrhea can cause not only financial difficul-
ties, but also emotional distress for caregivers: Parents
may feel frustrated that they cannot help their sick child,
frightened by the severity of the illness, and fatigued by
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countries, parents whose children were hospitalized for
rotavirus-associated diarrhea reported higher levels of
stress as compared to those whose children were seen in
an outpatient or emergency room setting [25]. Percep-
tions of financial stress differed in the above two studies
(both in developed settings) [24,25], but were not expli-
citly compared with actual incurred financial difficulty.
A review of the literature did not find any studies dir-
ectly comparing financial stress or perceived cost burden
to actual incurred cost burden.
The aim of this report is to describe total incurred costs
and cost burden associated with caregivers seeking treat-
ment for pediatric gastroenteritis across six Bolivian hospi-
tals. The first objective is to quantify these costs. The
second objective is to better understand the relationships
among costs, treatment setting, and appointment type. An
additional objective is to understand the relationships
among perceptions of cost and actual incurred cost bur-
den. These results should further complement a study
from 2011, where the impact of pediatric gastroenteritis to
the entire Bolivian health care system was estimated, and
helped provide the rationale for introduction of the rota-
virus vaccination program in 2008 [26].Methods
Study population
The data presented were collected through a collaboration
between Emory University in the United States and
Bolivia’s “Instituto de Biología Molecular y Biotecnología
de la Universidad Mayor de San Andrés” (IBMB, Bolivia)
between 2007 and 2009. Study participants were inter-
viewed in hospitals and outpatient clinics in four cities in
Bolivia: La Paz, El Alto, Cochabamba, and Santa Cruz. In
all, six sentinel hospitals were included (Hospital Boliviano
Holandés in El Alto, Hospital Materno Infantil and
Hospital del Niño in La Paz, Centro Pediatria Albino R.
Patiño and Hospital German Urquidi in Cochabamba, and
Hospital Mario Ortiz Suarez in Santa Cruz). All six hospi-
tals are sentinel sites located in the four major cities of
Bolivia. These sites include both privately and publicly
funded hospitals as well as pediatric and general hospitals,
and all provide in- and out-patient care. All hospitals were
located in primarily urban / peri-urban areas, but did draw
some patients from rural areas or peri-urban areas as well.
Study participants were identified by nurses, doctors,
and study staff, based on a primary diagnosis of acute diar-
rhea (inpatients) or treatment for acute diarrhea (outpa-
tients). Diagnoses were confirmed by clinicians. Eligibility
criteria were as follows: patient was a child of less than
5 years of age, with a primary diagnosis of acute, non-
bloody diarrhea; parent / caregiver was at least 18 years of
age. Parents / guardians were consented by study staff.The total sample size of 1,107 was estimated according
to the “Guidelines for Estimating the Economic Burden
of Diarrheal Disease With Focus on Assessing the Costs
of Rotavirus Diarrhea” [9]. To achieve a 10% precision
and 0.5 coefficient of variation for each hospital, at least
49 records were collected from each hospital. From
these 1,107, a total of 874 had complete demographic in-
formation and are included in Table 1. Of this popula-
tion, 535 observations had complete cost data and
sufficient sample size for analysis of cost burden. Given
sample size considerations, only inpatient (N=250) and
outpatient (N=285) visits were considered from the six
hospitals. Due to inappropriate sample sizes for analyses
(< 10 children), for hospital German Urquidi, inpatient
visits were excluded, and for Hospitals Materno Infantil
and Del Niño, outpatient visits were excluded.
Ethical approval
Prior to data collection, all portions of the study, includ-
ing inpatient and outpatient chart abstraction, were ap-
proved by Emory University’s Institutional Review and
the Bolivian National Bioethics Committee.
Data collection
The costs of treating diarrhea were determined by con-
ducting surveys with parents of sick children. The survey
was developed based on guidance from the World Health
Organization document “Guidelines for Estimating the
Economic Burden of Diarrheal Disease with Focus on
Assessing the Costs of Rotavirus Diarrhea” [9]. Parents
and guardians of inpatient children were surveyed by re-
searchers within a week of hospitalization. Parents and
guardians of outpatient children were surveyed by study
investigators while waiting for the outpatient appointment.
Data were collected primarily during the winter months in
Bolivia (May – September), given the seasonality of acute
diarrheal illness in this population.
Data management
All data were recorded by study investigators and stored
in Epi-Info version 3.5.2. Two independent researchers
entered the same data twice, data discrepancies were
identified and documented, and discrepancies were re-
solved by consulting the original survey. Data were
cleaned in SAS version 9.3 (Cary, NC).
Direct medical costs were defined as the costs of the
consultation, drugs, tests, and any previous treatment for
the same episode of diarrhea. Direct non-medical costs
were defined as the cost of food during hospitalization or
when waiting for the consultation, transportation from
home to hospital, and caring for children when parents
were in the hospital (including diapers and food). Indirect
costs were defined as lost productivity of parents and
guardians, determined using a function of salary and time
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548 186 82 145 79
(62.7) (46.3) (73.2) (99.3) (36.9)
OUTPATIENTS
326 216 30 1 135
(37.3) (53.7) (26.8) (0.7) (63.1)
TOTAL CHILDREN 2
874 402 112 146 214
(46.0) (12.8) (16.7) (24.5)
Median (25%, 75%)
HOSPITALIZED2,3
Number of days child had diarrhea prior to
visit
3.0 3.0 3.0 4.0 3.0
(2.0, 5.0) (1.0, 5.0) (2.0, 6.0) (3.0, 6.0) (2.0, 5.0)
Patient’s age (months)
11.0 9.0 11.0 11.0 11.0
(6.0, 15.0) (6.0, 15.0) (8.0, 15.0) (8.0, 16.0) (6.0, 16.0)
Monthly household income (US$)
152.06 151.20 115.20 144.00 172.80
(86.40, 288.00) (60.48, 288.00) (76.32, 216.00) (86.40, 273.60) (100.80, 259.20)
OUTPATIENTS2,3










(7.0, 17.0) (7.0, 17.0) (4.0, 13.0) (5.0, 22.0)




(100.80, 288.00) (86.40, 288.00) (115.20, 216.00) (144.00, 345.60)
1There were substantial missing data for urban vs. rural residence—40.2% of observations were missing this information. Data from El Alto and La Paz are
excluded from this comparison due to near-complete missing information.
2Percentages are calculated out of the total hospitalized and outpatient sample size.
3The inpatient appointment Hospital German Urquidi and the outpatient appointment Hospital Del Nino and Hospital Materno-Infantil were not analyzed due to
insufficient data.
†Significantly different from Santa Cruz (p<0.01), using Kruskal-Wallis test followed by post-hoc pairwise comparison.
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episode of diarrhea. Monthly family income was calculated
from a function of daily, weekly, or monthly salary, and
days worked per month as reported by the parents. The
incomes of both parents were summed to create the total
family income. The cost burden incurred by the families
due to one episode of diarrhea was defined as the total dir-
ect and indirect costs incurred by the family divided by
their annual household income and expressed as a per-
centage. Costs in Bolivianos (BOB) were converted into
USD using the second quarter 2011 exchange rate of 1
BOB equal to US$0.144. Perceptions of the impact of in-
curred costs were assessed on a five-point Likert scale re-
sponse to the question “Do you feel that paying for thetreatment of your child’s diarrhea has affected your family
finances? How much?” Responses of 4 (“More or less”)
and 5 (“A lot”) were coded as “Yes,” while all other re-
sponses were coded as “No.” Data were also collected on
the presence or absence of complications and comor-
bidities such as dehydration, vomiting, hypokalemia, meta-
bolic acidosis, electrolyte disorders, malnutrition, anemia,
bronchopneumonia, and acute respiratory infection, or an-
other unspecified comorbidity or complication.
Statistical analysis
Statistical analysis was completed using SAS version 9.3.
Chi-squared tests were used to compare two propor-
tions. Because cost data were not normally distributed,
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When comparing medians between two groups, the
Wilcoxon-Mann Whitney test was used. When compar-
ing medians among multiple groups, the Kruskal-Wallis
test was used, followed by post-hoc pairwise compari-
sons. The Cochran-Armitage test for trend was used to
assess trend of cost perception by levels of cost burden.
P values less than 0.05 were considered significant.
Results
The primary aim of this study was to describe direct and
indirect costs and the cost burden (total direct and in-
direct costs incurred by the family, as a percentage of
their annual household income) associated with care-
givers seeking treatment for pediatric gastroenteritis
across six different Bolivian healthcare settings.
Among 548 inpatient surveys and 326 outpatient sur-










Number of days child had diarrhea prior to visit 3.0
(2.0, 5
Patient’s age (months) 10.0
(5.0, 15
Monthly household income (US$) 172.8
(93.60, 28
OUTPATIENTS
Number of days child had diarrhea prior to visit 3.0
(2.0, 5
Patient’s age (months) 11.0
(7.0, 17
Monthly household income (US$) 172.8
(100.80, 2
1Results should be interpreted with caution due to large amount of missing data (4
2Percentages are calculated out of the column sample size.
3Bolded numbers are significantly different by a Kruskal-Wallis test at an alpha levelocation, the gender distribution among patients was
approximately equal among the different cities, and
within this population, 56% were male patients (Table 1).
There were no significant differences among cities in
the duration of diarrheal episode or patient age. The
median monthly income was not significantly different
between families of inpatient and outpatient children.
However, within outpatients, familial income was sig-
nificantly higher in Santa Cruz as compared to Cocha-
bamba (p<0.025) and El Alto (p<0.002) (Table 1). In
summary, only familial income was significantly diffe-
rent between different cities when stratified on appoint-
ment type.
Given that costs can also be different by urban as
compared to rural residence, we also examined the
distribution of demographics by residence location
(Table 2). Overall, approximately 83% of participants














.0) (2.0, 5.0) (2.0, 5.0)
10.0 7.0
.0) (6.0,15.0) (3.0, 15.0)
0 172.80 139.68
8.00) (93.60, 266.40) (86.40, 291.60)
3.0 4.0
.0) (2.0, 5.0) (2.0, 7.0)
10.5 12.0
.0) (7.0, 17.0) (7.0, 198.0)
0 172.80 172.80
88.00) (113.76, 288.00) (7.20, 288.00)
0.2%) on rural / urban residence status.
l of 0.05.
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number of days ill prior to present treatment, which
was significantly higher for rural participants.
Since comorbidities can increase the cost of treatment,
data were also collected on the child’s comorbidities and
presenting complications. Of those with complete data
(623 of 971), 40% of children presented with vomiting,
65% with dehydration, 10% with malnutrition, 9% with
anemia, 6% with acute respiratory infection or broncho-
pneumonia, 14% with some electrolyte imbalance, and
13% with some other unspecified complication. Overall,
53% of study participants presented with some type of
comorbidity or complication. Median total incurred
costs were significantly higher (p<0.0001) among those
presenting with at least one comorbidity or complica-
tion, as compared to those presenting with none (US$42
vs. US$26) (data not shown).
To understand potential correlates of caregiver costs,
direct, indirect, and total incurred costs were stratified
by type of residence and appointment (Table 3). This
analysis was limited to 535 patients (250 inpatients and
285 outpatients) with complete cost burden data. Direct
and indirect costs were significantly higher for inpatient
care than outpatient care. Overall, total incurred costs
were also significantly higher for inpatients than for out-
patients. When total incurred costs for the entire study
population were broken down by type of expenditure,
consult fees totaled 30% of the incurred costs, indirect
costs accounted for another 29%, and direct non-











Non-Medical Costs (e.g., Travel, child care) 4.03†
(2.63, 6.30)




1Only children with complete information on appointment type, hospital, and cost
†Significantly different from Urban Outpatients, p<0.001.
‡Significantly different from Rural Outpatients, p<0.05.consult fees and indirect costs, compared to other costs
due to diarrheal episodes, were a large relative burden
upon families and caregivers.
To assess the seriousness of an episode of pediatric
gastroenteritis to the Bolivian family, the distribution of
the cost burden was analyzed (Figure 1). Cost burdens
ranged from less than 1% up to 38.17% (median 0.83%,
IQR 1.83%), with 10 patients (1.9%) showing a cost bur-
den of at least 10%. Though a majority (54.8%) of pa-
tients’ families experienced a cost burden of less than
1%, 45% of the patients’ families had to pay at least 1%
of their annual household income for this single episode
of diarrhea. For a family with the median annual income
of US$1,749 (data not shown), a cost burden of 1%
would translate into US$17.49 spent on a single episode
of diarrhea. This could represent between three and five
days of food and fuel for an average family of four per-
sons, depending on the level of food security of the fam-
ily [27]. Viewed through another lens, this amount is
twice as much as the average monthly expenditure on
intra-city transportation reported for Bolivians of “indi-
gent” poverty in 2008 [28]. Inpatients (59.4%), compared
to outpatients (33.7%), had a significantly higher fre-
quency of paying more than 1% of their annual house-
hold income for this single episode of diarrhea and had
a significantly higher median cost burden as well (1.36%
inpatient versus 0.60% outpatient).
Additionally, relationships between actual incurred
costs and perceptions of costs were explored. Overall,
68.5% of caregivers felt that diarrheal costs weretric diarrhea (US$)1
n Rural
Outpatients (N=230) Hospitalized (N=31) Outpatients (N=49)
Median (Q1, Q3)
4.79 26.50‡ 6.91
(1.87, 14.54) (9.07, 67.68) (3.6, 18.72)
0.00 0.00 0.00
(0.00, 0.00) (0.00, 0.00) (0.00, 0.00)
0.00 5.76 0.00
(0.00, 5.04) (0.00, 12.96) (0.00, 5.83)
0.00 3.60‡ 0.00
(0.00, 0.00) (0.00, 46.08) (0.00, 0.00)
2.88 6.34 4.48
(1.30, 5.62) (3.31, 9.36) (2.74, 9.50)
1.23 20.34‡ 8.64
(0.00, 13.37) (11.52, 27.60) (0.00, 24.48)
10.74 32.40‡ 17.63



















































Percent of Families in Category Cumulative Percent of Families
Figure 1 Breakdown of cost burden categories. Over 40% of
Bolivian families in this study spent at least 1% of their annual
income on a single episode of pediatric diarrhea. The black bars
represent percentage of patients in each cost burden category. The
gray line shows the cumulative percentage of patients in or below
the current cost burden category. Each cost burden category, on
the X axis, represents a range of one percentage point, for example,
0%=0 - <1%, 1%=1% - <2%. Only pediatric visits with complete cost
records and hospital data were analyzed (N=535).
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dents reporting that cost affected family finances (4–5
on a Likert scale of 1–5) was significantly higher within
higher levels of actual cost burden (p<0.001 for trend),
with only 54% of those with a cost burden between 0 and
1% believing that the cost substantially affected family
finances, as compared to 85% of those with a cost bur-
den of at least 3%.
Discussion
The objective of the present study was to describe the
direct and indirect costs and the cost burden associated
with caregivers seeking treatment for pediatric gastro-
enteritis at inpatient and outpatient settings in Bolivia.
Families in this study incurred substantial costs for both
inpatient and outpatient visits associated with pediatric
diarrhea. Inpatient appointments were significantly more
expensive than outpatient visits when considering indi-
rect, direct, and total incurred costs. Additionally, indi-
rect costs due to diarrheal episodes, though likely
underestimated in the present study, were shown to be a
large burden upon families and caregivers. Overall, most
families felt that the diarrheal episode had a negative im-
pact on their financial situation. These results demon-
strate the high cost of inpatient care and the importance
of indirect costs in an overall view of incurred familial
costs associated with pediatric diarrhea.
This study demonstrated that the total incurred costs
due to diarrheal episodes for inpatients were significantly
higher than those associated with outpatient visits
(Table 3). These costs are not negligible: total costs for a
single episode of diarrhea in outpatients (median US$11.66) may represent between two and three days of
food and fuel for a family of four, while those for hospi-
talized patients (median US$23.44) may represent be-
tween four and six days of food and fuel for a family of
four, depending on the family’s level of food security
[27]. Findings of greater costs for hospitalized patients
were consistent with other studies of diarrheal costs
in India and China, which also demonstrated higher
familial incurred costs for inpatients as compared to out-
patients [20,22,23]. Inpatient episodes (hospitalization)
could result in higher direct and indirect costs due to re-
quired longer hospital stays, higher medical fees, and a
greater need for the caregiver to take time off from
work. Also consistent with studies in Vietnam [6] and
India [20], indirect and nonmedical direct costs in our
study were generally higher for rural patients as com-
pared to urban patients, with higher rural indirect costs
primarily seen in the ambulatory setting. This could be
explained by a greater distance between the family’s
home and the hospital or clinic, leading to higher trans-
portation costs and a greater need for caregivers to take
time off from work. Indeed, travel costs were signifi-
cantly higher among rural families in our study, and the
number of days the child had been ill prior to seeking
the current treatment were also significantly longer
(indicating a potential delay of treatment). Overall, data
indicate that both direct and indirect costs are burden-
some for Bolivian families of pediatric diarrhea patients,
with the burden particularly high for rural families and
those whose children are hospitalized.
A majority of patients had a cost burden of less than
1%. Cost burden estimates in similar studies ranged from
2.2% to 5.8% in India and up to 37% in Uzbekistan
[20,29]. In this study, cost burden was generally higher
for inpatients as compared to outpatients, reflecting the
overall greater cost associated with hospitalization in
Bolivia [26]. Though the cost burden of a single diar-
rheal episode was minimal for many caretakers in this
study, nearly 45% of surveyed families spent at least 1%
of their income on just one diarrheal episode. In this
study, the 1.9% of patients experiencing cost burdens of
at least 10% were found to have a range of familial in-
comes, from very low (US$7.20 per month) up to slightly
above the median income within the study population
(US$158.40 per month), demonstrating that families
from a variety of income levels can experience a tremen-
dous burden from even a single diarrheal episode. On
the whole, this study population would be considered
quite poor even within Bolivia: the median per capita in-
come (US$45.43 per month) in the study population is
nearly identical to the “Indigent Poverty” per capita in-
come for Bolivia as calculated in 2000 ($45.20 per
month) [4]. This may reflect an overall disparity in rates
of pediatric gastroenteritis among different income
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budget and may spend over 60% of income on food and
fuel (leaving little extra for healthcare, education, and
housing expenses) [27], the cumulative economic impact
of multiple pediatric diarrheal episodes may devastate a
household’s overall financial well-being.
The results of the present study demonstrate that in
Bolivia, indirect costs, such as lost wages, constituted a
considerable fraction of the overall costs to caregivers
and families. In a cost-of-illness study from Brazil [30],
indirect costs accounted for 20% of total costs for inpa-
tients, and 72% of total costs for outpatients, which is
consistent with our own estimates and those reported in
2007 for the Latin American region by Rheingans et al.
[15]. While these findings are consistent with two other
studies, conducted in British and Canadian children
[31,32], several other studies examining family-incurred
costs for pediatric diarrhea in LMIC did not find indirect
costs to make up a substantial proportion of overall
costs [13,20,21,29]. There were several other differences
in the methodology and study population between the
present study and other studies on costs associated with
pediatric diarrhea that may help to account for the dis-
tinct findings. While the other studies in LMIC used
caregiver-reported daily wages and time lost from work
to develop estimates of indirect costs (as in the present
analysis) [13,20-23,29,33], studies with British and Canadian
children used country mean daily wage values (and
caregiver-reported time lost from work) to calculate in-
direct costs; further, parents in the British study did not
incur any direct medical costs beyond over-the-counter
medications [31,32]. In the studies where indirect costs
were minimal, the authors mentioned difficulty in calcu-
lating average daily wages (e.g. because caregivers were
employed informally and thus unable to estimate daily
wages), as well as a low percentage of surveyed caregivers
actually having missed work (because the caregiver who
attended the sick child did not earn an income) as possible
reasons for the low contribution of indirect costs. It’s pos-
sible that the present study found greater indirect costs
due to the seemingly higher prevalence of income-
generating activities by both spouses, as opposed to just
one. Because the present study demonstrated that indirect
costs were important to overall diarrhea-related costs in
Bolivia, future economic studies and cost-effectiveness
analyses focusing on societal costs in other countries
should include indirect costs in their analyses.
This study also found that most families felt that the
cost of the diarrheal episode had an impact on family fi-
nances. This is in contrast to a study on pediatric rota-
virus infection in Canada, in which few families reported
feeling that indirect costs (missing work) were impacting
their family income [24]. However, most of these Canadian
families were beneficiaries of paid absence or FamilyMedical Leave Allowance programs [24], while the Bolivian
families in this study had no similar compensation for
missing work. In addition, in the present study, the per-
centages of caregivers reporting that the episode affected
them financially were higher as the actual cost burden in-
creased. It’s possible that this reflects sensitivity on the part
of the caregivers with regards to the real impact of cost
burden. This finding suggests a need for research on care-
giver costs to identify predictors of actual incurred cost
and cost burden, which may in turn help to address the
emotional stresses associated with this cost.
One strength of this study was the generalizability of its
results to Bolivia because of the wide breadth of health
care sites, covering multiple geographic regions of Bolivia
and two types of health care settings (outpatient and in-
patient). A second strength was the detail (i.e. multiple
types of costs) with which data were collected. One limita-
tion was that the cost estimates in this study are likely an
underestimate of the true cost estimates because the care-
giver sometimes was unable to provide specific cost infor-
mation. A second limitation was that not all sites had
sufficient sample sizes for a statistically meaningful com-
parison. Finally, the cross-sectional design of the study
makes it challenging to examine the long term economic
implications to the household resulting from death or
other health consequences.
Conclusion
In conclusion, this study has shown that indirect costs
were a non-negligible component of a child’s diarrheal
episode and that a single diarrheal episode affected the
actual and perceived financial situation of a large num-
ber of caregivers. The Bolivian Rotavirus Surveillance
Program estimates that, without vaccination, rotavirus
alone causes over 47,000 outpatient visits, more than
9,000 hospitalizations, and 813 deaths each year [26].
Using data from the present paper, as well as a previ-
ously published cost-effectiveness analysis of the rota-
virus vaccine in the Bolivian setting, we estimate that
Bolivian families suffered pediatric diarrhea-related
costs of US$2.8MM annually (range US$2.0MM to US
$3.6MM), in this era prior to wide rotavirus vaccine im-
plementation (data not shown) [26]. With the imple-
mentation of the rotavirus vaccine in Bolivia in 2008
[34-36], the number and severity of rotavirus diarrhea
episodes, and therefore the societal costs due to diar-
rhea, are expected to decrease nationwide. The present
data serve as a baseline for societal diarrheal costs
before and immediately following the implementation
of the rotavirus vaccine and highlight the serious eco-
nomic importance of a diarrheal episode to Bolivian
caregivers and the overall economic situation of the
country, even in a setting with universal healthcare
coverage for children.
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